|
1
|
Shiseki M, Nagashima M, Pedeux RM, et al:
p29ING4 and p28ING5 bind to p53 and p300 and enhance p53 activity.
Cancer Res. 63:2373–2378. 2003.PubMed/NCBI
|
|
2
|
Byron SA, Min E, Thal TS, et al: Negative
regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
PLoS One. 7:e468232012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with downregulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li M, Jin Y, Sun WJ, et al: Reduced
expression and novel splice variants of ING4 in human gastric
adenocarcinoma. J Pathol. 219:87–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lou C, Jiang S, Guo X and Dong XS: ING4 is
negatively correlated with microvessel density in colon cancer.
Tumour Biol. 33:2357–2364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang QS, Li M, Zhang LY, et al:
Down-regulation of ING4 is associated with initiation and
progression of lung cancer. Histopathology. 57:271–281. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Zhang Q, Cai L, et al: Inhibitor of
growth 4 induces apoptosis in human lung adenocarcinoma cell line
A549 via Bcl-2 family proteins and mitochondria apoptosis pathway.
J Cancer Res Clin Oncol. 135:829–835. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen JC, Unoki M, Ythier D, et al:
Inhibitor of growth 4 suppresses cell spreading and cell migration
by interacting with a novel binding partner, liprin alpha1. Cancer
Res. 67:2552–2558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Colla S, Tagliaferri S, Morandi F, et al:
The new tumor-suppressor gene inhibitor of growth family member 4
(ING4) regulates the production of proangiogenic molecules by
myeloma cells and suppresses hypoxia-inducible factor-1 alpha
(HIF-1alpha) activity: Involvement in myeloma-induced angiogenesis.
Blood. 110:4464–4475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J and Li G: Cell cycle regulator ING4
is a suppressor of melanoma angiogenesis that is regulated by the
metastasis suppressor BRMS1. Cancer Res. 70:10445–10453. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santisteban M, Reiman JM, Asiedu MK, et
al: Immune-induced epithelial to mesenchymal transition n
vivo generates breast cancer stem cells. Cancer Res.
69:2887–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song GQ and Zhao Y: Different therapeutic
effects of distinct KISS1 fragments on breast cancer n vitro
and n vivo. Int J Oncol. 43:1219–1227. 2013.PubMed/NCBI
|
|
18
|
Lokman NA, Elder AS, Ricciardelli C and
Oehler MK: Chick chorioallantoic membrane (CAM) assay as an n
vivo model to study the effect of newly identified molecules on
ovarian cancer invasion and metastasis. Int J Mol Sci.
13:9959–9970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Apte U, Zeng G, Thompson MD, et al:
beta-Catenin is critical for early postnatal liver growth. Am J
Physiol Gastrointest Liver Physiol. 292:G1578–G1585. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nejak-Bowen K and Monga SP:
Wnt/beta-catenin signaling in hepatic organogenesis. Organogenesis.
4:92–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brown AM: Wnt signaling in breast cancer:
Have we come full circle? Breast Cancer Res. 3:351–355. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J and Zhou BP: Activation of β-catenin
and Akt pathways by Twist are critical for the maintenance of EMT
associated cancer stem cell-like characters. BMC Cancer. 11:492011.
View Article : Google Scholar : PubMed/NCBI
|
